iBio, Inc. - Common Stock, par value $0.001 per share (IBIO)
CUSIP: 451033708
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 30,719,795
- Total 13F shares
- 2,607,512
- Share change
- +156,394
- Total reported value
- $5,788,674
- Price per share
- $2.22
- Number of holders
- 31
- Value change
- +$356,141
- Number of buys
- 6
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 451033708?
CUSIP 451033708 identifies IBIO - iBio, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 451033708:
Top shareholders of IBIO - iBio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC |
13F
|
Company |
2%
|
600,000
|
$1,266,000 | — | 30 Jun 2024 | |
| Lynx1 Capital Management LP |
13F
|
Company |
2%
|
600,000
|
$1,266,000 | — | 30 Jun 2024 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
1.9%
|
570,000
|
$1,202,700 | — | 30 Jun 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
1.2%
|
375,000
|
$791,250 | — | 30 Jun 2024 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.52%
|
159,535
|
$336,619 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
49,197
|
$103,805 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
40,669
|
$85,811 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.12%
|
35,998
|
$75,956 | — | 30 Jun 2024 | |
| Randy Joe Maddux |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
271,757
|
$72,151 | — | 07 Dec 2021 | |
| Robert Matthew Lutz |
3/4/5
|
Chief Financial & Business Officer and Principal Accounting Officer |
—
class O/S missing
|
102,165
|
$27,125 | — | 11 Nov 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.03%
|
10,165
|
$21,448 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
5,574
|
$11,761 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,361
|
$7,092 | — | 30 Jun 2024 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
1,000
|
$2,110 | — | 30 Jun 2024 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
215
|
$454 | — | 30 Jun 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0%
|
156
|
$329 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
71
|
$150 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
56
|
$118 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
49
|
$103 | — | 30 Jun 2024 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
40
|
$84 | — | 30 Jun 2024 | |
| SOA Wealth Advisors, LLC. |
13F
|
Company |
0%
|
13
|
$27 | — | 30 Jun 2024 | |
| Activest Wealth Management |
13F
|
Company |
0%
|
4
|
$8 | — | 30 Jun 2024 | |
| CITY HOLDING CO |
13F
|
Company |
0%
|
4
|
$8 | — | 30 Jun 2024 | |
| Steward Partners Investment Advisory, LLC |
13F
|
Company |
0%
|
3
|
$6 | — | 30 Jun 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
2
|
$4 | — | 30 Jun 2024 | |
| Financial Gravity Asset Management, Inc. |
13F
|
Company |
0%
|
2
|
$4 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2
|
$4 | — | 30 Jun 2024 | |
| Arax Advisory Partners |
13F
|
Company |
0%
|
1
|
$3 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1
|
$2 | — | 30 Jun 2024 | |
| Thomas F. Isett |
3/4/5
|
CEO and Executive Chairman, Director |
—
class O/S missing
|
2,000,000
|
— | — | 08 Sep 2022 | |
| General Hill (ret) James T. |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| Glenn Chang |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| John D. McKey Jr. |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 | |
| Linda Washington Armstrong |
3/4/5
|
Director |
—
class O/S missing
|
109,000
|
— | — | 09 Dec 2021 |
Institutional Holders of iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) as of Q3 2024
As of 30 Sep 2024,
iBio, Inc. - Common Stock, par value $0.001 per share (IBIO) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,607,512 shares.
The largest 10 holders included
Lynx1 Capital Management LP, Ikarian Capital, LLC, ADAR1 Capital Management, LLC, Opaleye Management Inc., BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, NORTHERN TRUST CORP, and BlackRock, Inc..
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
26
Q3 2024 holders
31
Holder diff
5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.